Baird Q2 Preview on Affymax, Inc. (AFFY): Expectations are Low, But Survey Highlights Positive Data
Tweet Send to a FriendGet Alerts AFFY Hot Sheet
Price: $1.40 -3.45%
Rating Summary:
6 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 27 | New: 13
Rating Summary:
6 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 27 | New: 13
Trade AFFY Now!
Baird reiterates an 'Outperform' on Affymax, Inc. (NASDAQ: AFFY), new price target of $18.00.
Analyst, Christopher Raymond, said, "Heading into Q212 earnings, (anticipate early August), we think expectations are low, given late April launch/traditionally slow nephrology ramps. However, as a new survey highlights, current Omontys use is measurable and expected uptake is meaningfully ahead of our model. Given nephrologists' historical tendencies to overstate preference-share, and given that dialysis is highly contract-driven, we wouldn't necessarily go overboard on these data. Nonetheless, this feedback is encouraging and supports our anticipation of a successful launch."
For an analyst ratings summary and ratings history on Affymax, Inc. click here. For more ratings news on Affymax, Inc. click here.
Shares of Affymax, Inc. closed at $14.24 yesterday, with a 52 week range of $3.93-$16.25.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Christopher Raymond, said, "Heading into Q212 earnings, (anticipate early August), we think expectations are low, given late April launch/traditionally slow nephrology ramps. However, as a new survey highlights, current Omontys use is measurable and expected uptake is meaningfully ahead of our model. Given nephrologists' historical tendencies to overstate preference-share, and given that dialysis is highly contract-driven, we wouldn't necessarily go overboard on these data. Nonetheless, this feedback is encouraging and supports our anticipation of a successful launch."
For an analyst ratings summary and ratings history on Affymax, Inc. click here. For more ratings news on Affymax, Inc. click here.
Shares of Affymax, Inc. closed at $14.24 yesterday, with a 52 week range of $3.93-$16.25.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- KeyBank Upgrades MDC Holdings (MDC); Cuts PulteGroup (PHM) & Ryland Group (RYL)
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- Deutsche Bank Raises PT on NetApp (NTAP) to $48
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Robert W Baird, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
